Tribenzor Tablet, Film Coated
Product Images NDC 0713-0874

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Tribenzor (NDC 0713-0874). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cosette Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Structural Formula For Olmesartan Medoxomil Is Hydrolyzed To Olmesartan During Absorption From The Gastrointestinal Tract. (Tribenzor 01)

Chemical structure diagram of the active ingredient olmesartan medoxomil, part of the medication Tribenzor.*

FDA Label Image

The Structural Formula For Amlodipine Besylate Is Chemically Described As 3 Ethyl 5-methyl (±)-2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate, Monobenzene (Tribenzor 02)

Chemical structure of olmesartan medoxomil, one of the active ingredients in Tribenzor, shown alongside a molecule of benzenesulfonic acid, corresponding to the besylate component of amlodipine besylate.*

FDA Label Image

The Structural Formula For Hydrochlorothiazide Is Chemically Described As 6 Chloro 3,4-dihydro-2h-1,2,4-benzo-thiazidiazine-7-sulfonamide 1,1-dioxide. Its Empirical Formula Is C7h8cin3o4s2. (Tribenzor 03)

Chemical structure diagram of olmesartan medoxomil, one of the active ingredients in Tribenzor tablets. The diagram shows the molecular framework with labeled functional groups and atoms.*

FDA Label Image

Figure 1: Mean Ambulatory Diastolic Blood Pressure At Endpoint By Treatment And Hour (Tribenzor 04)

Line graph depicting mean ambulatory diastolic blood pressure (mmHg) over 24 hours post dose. The x-axis represents hours post dose from 0 to 24, and the y-axis shows blood pressure values ranging from 55 to 100 mmHg. Multiple treatment groups are plotted including Baseline, AML10/HCTZ25, OM40/AML10/HCTZ25, and others with different marker symbols for comparison.*

FDA Label Image

Figure 2: Mean Ambulatory Systolic Blood Pressure At Endpoint By Treatment And Hour (Tribenzor 05)

Line graph showing mean ambulatory systolic blood pressure (mmHg) over 24 hours post dose. The x-axis represents hours post dose from 0 to 24, and the y-axis shows systolic BP values from 105 to 160 mmHg. Multiple treatment groups are plotted including Baseline, OM40/AML10, OM40/AML10/HCTZ25, AML10/HCTZ25, and OM40/HCTZ25, each represented by distinct line styles and markers.*

FDA Label Image

Principal Display Panel Ndc 0713-0874-30 Tribenzor (olmesartan Medoxomil, Amlodipine, Hydrochlorothiazide) Tablets 20 mg/5 mg*/12.5 mg 30 Tablets Rx Only (Tribenzor 06)

Label for Tribenzor tablets containing olmesartan medoxomil, amlodipine, and hydrochlorothiazide. The strength is 20 mg/5 mg/12.5 mg per tablet. The label indicates 30 tablets per package, marketed by Cosette Pharmaceuticals, Inc., with storage instructions and regulatory details visible.*

FDA Label Image

Principal Display Panel Ndc 0713-0875-30 Tribenzor (olmesartan Medoxomil, Amlodipine, Hydrochlorothiazide) Tablets 40 mg/5 mg*/12.5 mg 30 Tablets Rx Only (Tribenzor 07)

Packaging label for Tribenzor film-coated tablets containing olmesartan medoxomil, amlodipine, and hydrochlorothiazide with strengths of 40 mg, 5 mg, and 12.5 mg respectively. The label shows a package size of 30 tablets, marketed by Cosette Pharmaceuticals, Inc. Storage instructions and NDC 0713-0875-30 are visible.*

FDA Label Image

Principal Display Panel Ndc 0713-0876-30 Tribenzor (olmesartan Medoxomil, Amlodipine, Hydrochlorothiazide) Tablets 40 mg/5 mg*/25 mg 30 Tablets Rx Only (Tribenzor 08)

Label for Tribenzor tablets containing 40 mg olmesartan medoxomil, 5 mg amlodipine besylate, and 25 mg hydrochlorothiazide. The label indicates a film-coated oral tablet with 30 tablets per package, marketed by Cosette Pharmaceuticals, Inc. The label includes storage instructions and a barcode.*

FDA Label Image

Principal Display Panel Ndc 0713-0877-30 Tribenzor (olmesartan Medoxomil, Amlodipine, Hydrochlorothiazide) Tablets 40 mg/10 mg*/12.5 mg 30 Tablets Rx Only (Tribenzor 09)

Label for Tribenzor tablets containing olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide with a strength of 40 mg / 10 mg / 12.5 mg. The film-coated oral tablets are packaged in a quantity of 30. Marketed by Cosette Pharmaceuticals, Inc., South Plainfield, NJ, with storage instructions at 25°C (77°F) and a product origin of Germany.*

FDA Label Image

Principal Display Panel Ndc 0713-0878-30 Tribenzor (olmesartan Medoxomil, Amlodipine, Hydrochlorothiazide) Tablets 40 mg/10 mg*/25 mg 30 Tablets Rx Only (Tribenzor 0a)

Label for Tribenzor tablets containing olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide. The strength shown is 40 mg / 10 mg / 25 mg in film-coated tablet form. The label states marketing by Cosette Pharmaceuticals, Inc., and indicates a package count of 30 tablets. Storage instructions note 25°C with permitted excursions to 15-30°C. The product is marked Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.